Ertapenem
Carbapenems
Sold as INVANZ
- Drug class
- Carbapenems
- Availability
- Prescription only
- Routes
- Intramuscular, Intravenous
- Markets covered
- 4
- Products on record
- 24
- FDA reports (12 mo)
- 427
Overview
Ertapenem is an active pharmaceutical ingredient in the Carbapenems group (J01DH). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 12 | May 1, 2026 |
| CA Canada | Health Canada | 8 | June 1, 2026 |
| US United States | FDA | 2 | January 9, 2026 |
| EU European Union | EMA | 2 | November 21, 2025 |
GBUnited Kingdom· MHRA
12 products
Uses
4). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
How to take
CACanada· Health Canada
8 products
Uses
Treatment INVANZ® (ertapenem sodium) is indicated for the treatment of patients with the following moderate to severe infections caused by susceptible strains of the designated microorganisms (see 4 DOSAGE AND ADMINISTRATION). Complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides uniformis, or Bacteroides thetaiotaomicron.
Complicated skin and skin structure infections due to Staphylococcus aureus (methicillin- susceptible strain only), Streptococcus pyogenes, Escherichia coli and Peptostreptococcus species, as well as, diabetic foot infections due to Staphylococcus aureus (methicillin-susceptible strain only) and Peptostreptococcus species.
INVANZ® has not been studied in diabetic foot infections with concomitant osteomyelitis or severe ischemia (see 14 CLINICAL TRIALS). Community acquired pneumonia due to Streptococcus pneumoniae (penicillin-susceptible strain only), Haemophilus influenzae (β-lactamase negative strain only), or Moraxella catarrhalis.
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Ertapenem for injection is a penem antibacterial indicated in adult patients and pediatric patients (3 months of age and older) for the treatment of the following moderate to severe infections caused by susceptible bacteria: Complicated intra-abdominal infections.
1 ) Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis. 2 ) Community-acquired pneumonia. 3 ) Complicated urinary tract infections including pyelonephritis. 4 ) Acute pelvic infections including postpartum endomyometritis, septic abortion and post-surgical gynecologic infections.
5 ) Ertapenem for injection is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery. 6 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of ertapenem for injection and other antibacterial drugs, ertapenem for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
EUEuropean Union· EMA
2 products
Uses
4). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
How to take
Drug interactions
Known interactions involving Ertapenem. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL088280266 · revised March 13, 2026
- [2]Health Canada (DPD) · 02247437 · revised March 22, 2025
- [3]FDA DailyMed · 124775ed-1271-45… · revised January 9, 2026 [PDF]
- [4]European Medicines Agency · EMEA/H/C/000389 · revised November 21, 2025
- [5]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.